Research centers for clinical treatment (FKB) are funded by the Research Council of Norway. The centers are intended to help improve the treatment of Norwegian patients through excellent research.

The primary task is to conduct clinical studies. They will also contribute to transferring basic findings to clinical practice, increasing national and international collaboration, and educating competent clinicians and clinical researchers.

The centers have the opportunity to receive support from the Research Council for up to eight years (5 + 3 years). The maximum allocation is 160 million.

In addition to this, the research center itself provides its own funding that corresponds to the grants it receives.

The Olav Thon Foundation was established in 2013, with an emphasis on supporting charitable causes.

The foundation's statutes were amended at the end of 2021 to increase the annual payout from NOK 50 to 100 million.

Half of the budget will be earmarked for musculoskeletal purposes. This is part of founder Olav Thon's long-standing commitment to the societal consequences of musculoskeletal diseases.